Indolo[3,2-c]quinoline compounds
US7763633B2 · kind B2 · utility
1Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2009 |
| Grant date | Jul 27, 2010 |
| Priority date | — |
| Expiry date | Apr 9, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Indolo[3,2-c]quinoline compounds of formula (I) shown below. Each variable in this formula is defined herein. These compounds can be used to inhibit both growth of cancer cells and activity of telomerase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.